Heartflow, Inc. (HTFL)

Heartflow, Inc. is a medical technology company that uses artificial intelligence and computational modeling to help physicians diagnose and manage coronary artery disease. Its software creates a personalized three-dimensional model of a patient's coronary arteries from a standard coronary CT angiography scan.

Its main product, the FFRct analysis, estimates how blockages affect blood flow to the heart without an invasive procedure, helping doctors decide which patients need further testing or treatment. The company also offers plaque analysis that quantifies and characterizes plaque in the arteries, as well as tools to help plan interventions. Its customers are hospitals, imaging centers and cardiology practices.

Founded in 2007, Heartflow is headquartered in Mountain View, California, and completed its initial public offering on the Nasdaq in 2025.